These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23551977)

  • 21. A single F153Sβ3 mutation causes constitutive integrin αIIbβ3 activation in a variant form of Glanzmann thrombasthenia.
    Koukouritaki SB; Thinn AMM; Ashworth KJ; Fang J; Slater HS; Du LM; Nguyen HTT; Pillois X; Nurden AT; Ng CJ; Di Paola J; Zhu J; Wilcox DA
    Blood Adv; 2023 Jul; 7(13):3180-3191. PubMed ID: 36884296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin α
    Hsia CH; Lu WJ; Lin KH; Chou DS; Geraldine P; Jayakuma T; Chang NC; Sheu JR
    J Cell Mol Med; 2018 Apr; 22(4):2142-2152. PubMed ID: 29369482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Ser162-->Leu mutation within glycoprotein (GP) IIIa (integrin beta3) results in an unstable alphaIIbbeta3 complex that retains partial function in a novel form of type II Glanzmann thrombasthenia.
    Jackson DE; White MM; Jennings LK; Newman PJ
    Thromb Haemost; 1998 Jul; 80(1):42-8. PubMed ID: 9684783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The β isoform of the catalytic subunit of protein phosphatase 2B restrains platelet function by suppressing outside-in αII b β3 integrin signaling.
    Khatlani T; Pradhan S; Da Q; Gushiken FC; Bergeron AL; Langlois KW; Molkentin JD; Rumbaut RE; Vijayan KV
    J Thromb Haemost; 2014 Dec; 12(12):2089-101. PubMed ID: 25330904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel 196Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann thrombasthenia.
    Nurden AT; Ruan J; Pasquet JM; Gauthier B; Combrié R; Kunicki T; Nurden P
    Platelets; 2002 Mar; 13(2):101-11. PubMed ID: 11897046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3.
    Afrasiabi A; Gelain F; Artoni A; Mannucci PM
    Platelets; 2008 Aug; 19(5):322-7. PubMed ID: 18791937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A unique phenotype of acquired Glanzmann thrombasthenia due to non-function-blocking anti-αIIbβ3 autoantibodies.
    Akuta K; Kashiwagi H; Yujiri T; Nishiura N; Morikawa Y; Kato H; Honda S; Kanakura Y; Tomiyama Y
    J Thromb Haemost; 2019 Jan; 17(1):206-219. PubMed ID: 30388316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversity of Glanzmann thrombasthenia in southern India: 10 novel mutations identified among 15 unrelated patients.
    Nelson EJ; Nair SC; Peretz H; Coller BS; Seligsohn U; Chandy M; Srivastava A
    J Thromb Haemost; 2006 Aug; 4(8):1730-7. PubMed ID: 16879215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method.
    Farsinejad A; Abolghasemi H; Kazemi A; Aghaiipour M; Hadjati E; Faranoush M; Jazebi M; Ala F
    Platelets; 2011; 22(5):321-7. PubMed ID: 21526886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A genetic analysis of integrin function: Glanzmann thrombasthenia in vitro.
    Baker EK; Tozer EC; Pfaff M; Shattil SJ; Loftus JC; Ginsberg MH
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1973-8. PubMed ID: 9050889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional Effect of the Mutations Similar to the Cleavage during Platelet Activation at Integrin β3 Cytoplasmic Tail when Expressed in Mouse Platelets.
    Shi X; Yang J; Cui X; Huang J; Long Z; Zhou Y; Liu P; Tao L; Ruan Z; Xiao B; Zhang W; Li D; Dai K; Mao J; Xi X
    PLoS One; 2016; 11(11):e0166136. PubMed ID: 27851790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization against α
    Fiore M; Bayat B; Phuangtham R; Blouin L; Huguenin Y; Bein G; Santoso S
    J Thromb Haemost; 2021 Jan; 19(1):255-261. PubMed ID: 33090654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel S527F mutation in the integrin beta3 chain induces a high affinity alphaIIbbeta3 receptor by hindering adoption of the bent conformation.
    Vanhoorelbeke K; De Meyer SF; Pareyn I; Melchior C; Plançon S; Margue C; Pradier O; Fondu P; Kieffer N; Springer TA; Deckmyn H
    J Biol Chem; 2009 May; 284(22):14914-20. PubMed ID: 19329429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Glanzmann thrombasthenia-like phenotype caused by a defect in inside-out signaling through the integrin alpha(IIb)beta3.
    Tomiyama Y; Shiraga M; Kinoshita S; Ambo H; Kurata Y; Matsuzawa Y; Kunicki TJ
    Thromb Haemost; 1998 Nov; 80(5):735-42. PubMed ID: 9843164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Truncation of the cytoplasmic domain of beta3 in a variant form of Glanzmann thrombasthenia abrogates signaling through the integrin alpha(IIb)beta3 complex.
    Wang R; Shattil SJ; Ambruso DR; Newman PJ
    J Clin Invest; 1997 Nov; 100(9):2393-403. PubMed ID: 9351872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Megakaryocyte-targeted synthesis of the integrin beta(3)-subunit results in the phenotypic correction of Glanzmann thrombasthenia.
    Wilcox DA; Olsen JC; Ishizawa L; Bray PF; French DL; Steeber DA; Bell WR; Griffith M; White GC
    Blood; 2000 Jun; 95(12):3645-51. PubMed ID: 10845892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.
    Nurden AT; Pillois X; Fiore M; Alessi MC; Bonduel M; Dreyfus M; Goudemand J; Gruel Y; Benabdallah-Guerida S; Latger-Cannard V; Négrier C; Nugent D; Oiron RD; Rand ML; Sié P; Trossaert M; Alberio L; Martins N; Sirvain-Trukniewicz P; Couloux A; Canault M; Fronthroth JP; Fretigny M; Nurden P; Heilig R; Vinciguerra C
    Hum Mutat; 2015 May; 36(5):548-61. PubMed ID: 25728920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glanzmann thrombasthenia: genetic basis and clinical correlates.
    Botero JP; Lee K; Branchford BR; Bray PF; Freson K; Lambert MP; Luo M; Mohan S; Ross JE; Bergmeier W; Di Paola J;
    Haematologica; 2020 Apr; 105(4):888-894. PubMed ID: 32139434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nonsynonymous SNP in the ITGB3 gene disrupts the conserved membrane-proximal cytoplasmic salt bridge in the alphaIIbbeta3 integrin and cosegregates dominantly with abnormal proplatelet formation and macrothrombocytopenia.
    Ghevaert C; Salsmann A; Watkins NA; Schaffner-Reckinger E; Rankin A; Garner SF; Stephens J; Smith GA; Debili N; Vainchenker W; de Groot PG; Huntington JA; Laffan M; Kieffer N; Ouwehand WH
    Blood; 2008 Apr; 111(7):3407-14. PubMed ID: 18065693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Leu117-->Trp mutation within the RGD-peptide cross-linking region of beta3 results in Glanzmann thrombasthenia by preventing alphaIIb beta3 export to the platelet surface.
    Basani RB; Brown DL; Vilaire G; Bennett JS; Poncz M
    Blood; 1997 Oct; 90(8):3082-8. PubMed ID: 9376589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.